Publication | Open Access
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial
39
Citations
21
References
2016
Year
Our results indicate that early development of rash identifies patients who derive superior benefit from lapatinib-based therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1